Navigation Links
New clues may link hereditary cancer genes to increased risk of cancer from alcohol
Date:1/23/2014

In laboratory experiments conducted on human cell lines at the Johns Hopkins Kimmel Cancer Center, scientists have shown that people carrying certain mutations in two hereditary cancer genes, BRCA2 and PALB2, may have a higher than usual susceptibility to DNA damage caused by a byproduct of alcohol, called acetaldehyde.

The scientists say they suspect that the two genes in their normal forms evolved to protect cells against the damaging effects of acetaldehyde, which can lead to cancer.

While the scientists caution that the research is preliminary, they say their findings suggest that studies on disease risk factors should take into account these particular genetic variations and the use of alcohol.

"We need to identify which behaviors in certain populations increase disease risk, and keep in mind that our genetic susceptibility plays a large role in cancer risk," says Scott Kern, M.D ., the Everett and Marjorie Kovler Professor in Pancreas Cancer Research at Johns Hopkins.

Acetaldehyde (pronounced ah-set-AL-deh-hide) is produced during the metabolism of alcohol and is known to cause DNA damage. Scientists say the chemical is ubiquitous in nature, found in many sources, including apples and gut bacteria, and is responsible for the "hangovers" people experience after heavy alcohol use. Alcohol use has long been linked to cancers of the upper aerodigestive tract, breast, pancreas, and stomach.

After reading reports linking acetaldehyde and a related chemical, formaldehyde, to a rare cancer-susceptibility disease called Fanconi anemia (which is characterized by mutations in BRCA2 and other genes), Kern and his team took a closer look at the growth response of cells exposed to acetaldehyde and other compounds. The team created human cell lines that lacked BRCA2 and PALB2 genes.

"You can add any chemical to a cell culture and growth of the cells will go down, so the significant responses are ones that differ by 10-fold or larger," says Kern.

The scientists found that BRCA2 and PALB2-mutant cell lines exposed to acetaldehyde had up to 25 times more growth reduction when compared with related cells lacking these mutations. The significant reduction in cell growth indicates that these cell lines, which lack the two genes, are more susceptible to the DNA damage caused by acetaldehyde, say the scientists. They suggest that the DNA-damaging effects of acetaldehyde exposure in people lacking these genes may accelerate cancer growth.

Kern and his team estimated that the BRCA2 and PALB2 genes, when they function normally, protect cells against up to 96 percent of the toxicity associated with acetaldehyde. Results of the experiments are published in the January 2014 issue of the American Journal of Pathology.

Kern says that the acetaldehyde model could, theoretically, be used to develop drugs that kill cancer cells, as well as to alter cancer risk. They found that cell lines with mutations in PALB2 were up to 20 percent more sensitive to chemotherapy agents, such as cisplatin, that work by breaking down DNA, compared with anticancer drugs that work in other ways.

When the genes function correctly, BRCA2 and PALB2 bind to each other to repair DNA damage. Mutations in the genes disable their DNArepairing capability and make carriers more susceptible to cancer, the researchers say.

"BRCA2 and PALB2 may have evolved over time to repair or protect us from acetaldehyde damage," says Kern. "In most people, the genes function well and we're equipped to handle most of our exposure to acetaldehyde, but patients or carriers with mutations in these genes could face a higher risk of cancers with high exposure to alcohol or acetaldehyde-containing foods."

Kerns says that there is a possibility acetaldehyde leaves a signature of damage in cells. He adds that scientists may have been overlooking the role of acetaldehyde in disease and aging.


'/>"/>

Contact: Vanessa Wasta
wasta@jhmi.edu
410-614-2916
Johns Hopkins Medicine
Source:Eurekalert

Related medicine news :

1. Stem cells offer clues to reversing receding hairlines
2. Clues to cocaines toxicity could lead to better tests for its detection in biofluids
3. Thomas Jefferson University Kimmel Cancer Center: Researchers Find New Clues to Treat Rare and Aggressive Inflammatory Breast Cancer
4. Scientists find potential new clues for identifying breast cancer risk
5. Alligator Study Gives Clues to Regrowing Lost Teeth
6. Scientists Discover More Genetic Clues to Testicular Cancer
7. Dog DNA May Yield Clues to Human Eczema
8. New genetic clues to breast and ovarian cancer
9. Mast cells give clues in diagnosis, treatment of dengue
10. Virus-like particles provide vital clues about brain tumors
11. Skin deep: Fruit flies reveal clues to wound healing in humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: